Vittiglio Joseph 4
4 · Finch Therapeutics Group, Inc. · Filed Mar 18, 2021
Insider Transaction Report
Form 4
Vittiglio Joseph
Chief Business & Legal Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-03-18+60,578→ 60,578 totalExercise: $17.00Exp: 2031-03-17→ Common Stock (60,578 underlying) - Award
Employee Stock Option (right to buy)
2021-03-18+34,616→ 34,616 totalExercise: $17.00Exp: 2031-03-17→ Common Stock (34,616 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on March 18, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]Twenty-percent (20%) of the shares subject to the option vest on December 7, 2021, and the remaining shares subject to the option shall vest in forty-eight (48) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.